Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 1,232,000 | 990,000 | 632,000 | 599,000 | 615,000 |
| Total expenses | 1,125,000 | 980,000 | 672,000 | 587,000 | 593,000 |
| Operating Income | 107,000 | 10,000 | -40,000 | 12,000 | 22,000 |
| Interest Expense | 145,000 | 132,000 | 136,000 | 119,000 | 32,000 |
| Other Income | 42,000 | 7,000 | -5,000 | 4,000 | 5,000 |
| Pre-tax Income | 4,000 | -115,000 | -181,000 | -103,000 | -5,000 |
| Income Tax | 28,000 | -501,000 | N/A | N/A | N/A |
| Net Income Continuous | -24,000 | 386,000 | -181,000 | -103,000 | -5,000 |
| Minority Interests | N/A | -2,000 | -1,000 | 1,000 | N/A |
| Net Income | $-24,000 | $388,000 | $-180,000 | $-104,000 | $-5,000 |
| EPS Basic Continuous Ops | -0.19 | 3.02 | -1.46 | -0.90 | -0.05 |
| EPS Basic Total Ops | -0.23 | 2.98 | -1.49 | -0.96 | -0.05 |
| EPS Diluted Continuous Ops | -0.19 | 2.72 | -1.46 | -0.90 | -0.05 |
| EPS Diluted Total Ops | -0.23 | 2.73 | -1.49 | -0.96 | -0.05 |
| EBITDA(a) | $272,000 | $180,000 | $20,000 | $81,000 | $86,000 |